Product Information
SULFASALAZINE 500 MG TABLET is a generic product labeled by Mylan Pharmaceuticals Inc., priced at $0.2003 per EA under NDC 59762500006. Its NADAC has been published 328 times since May 13, 2020.
FDA first approved this application before 1982. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The High Outlier badge above means this manufacturer's average price in the Sulfasalazine market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
500 mg/1
Manufacturer
Mylan Pharmaceuticals Inc.NDC
59762500006
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
SULFASALAZINEApproval Type
Authorized Generic (NDA)
FDA Application
NDA007073FDA Approved
Before 1982
TE Code
AB
On Market Since
7/1/2003
Pharmacological Classes
Price Statistics
The NADAC for SULFASALAZINE 500 MG TABLET has been published 328 times since May 13, 2020, and over the history we have for it it has risen 23.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2003 per EA |
|---|---|
| All-time high | $0.2003 (Aug 19, 2026) |
| All-time low | $0.1285 (Apr 17, 2024) |
| 52-week high | $0.2003 |
| 52-week low | $0.1779 |
| Median price | $0.1694 |
| Average price | $0.1714 |
| Largest weekly change | +31.0% (Aug 21, 2024) |
| Weeks tracked | 328 |
| Tracking since | May 13, 2020 |
Generic Alternatives
The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of SULFASALAZINE 500 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for SULFASALAZINE 500 MG TABLET, manufactured by Mylan Pharmaceuticals Inc., is $0.2003 per EA (NDC 59762500006), effective Aug 19, 2026.
How has the price of SULFASALAZINE 500 MG TABLET changed over time?
Over the history we have for it, the NADAC for SULFASALAZINE 500 MG TABLET has risen 23.2%. It has been tracked across 328 weekly CMS publications since May 13, 2020.
What are the highest and lowest recorded NADAC prices for SULFASALAZINE 500 MG TABLET?
Since May 13, 2020, the NADAC for SULFASALAZINE 500 MG TABLET has ranged from a low of $0.1285 (Apr 17, 2024) to a high of $0.2003 (Aug 19, 2026), with a median of $0.1694 per EA.
Are there cheaper alternatives to SULFASALAZINE 500 MG TABLET?
4 manufacturers publish a NADAC-priced product with the same active ingredient and strength as SULFASALAZINE 500 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures SULFASALAZINE 500 MG TABLET?
SULFASALAZINE 500 MG TABLET (NDC 59762500006) is labeled by Mylan Pharmaceuticals Inc., and CMS classifies it as a generic product.